IL-2 R gamma

IL-2 R gamma 詳細

英語名Interleukin-2 receptor subunit gamma市販薬剤の数0
治験薬の数14ターゲットの別称Common Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
研究&開発段階Phase 2 Clinical
英語名Interleukin-2 receptor subunit gamma
ターゲットの別称Common Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
市販薬剤の数0
治験薬の数14
研究&開発段階Phase 2 Clinical

IL-2 R gamma 製品リスト

  • 属性

    Protein (7)

  • 製品ライブラリ

    オンライン (7)

  • Human (3)Mouse (2)Rhesus macaque (1)Cynomolgus (1)

  • タグ

    Fc Tag (1)His Tag & Avi Tag (2)His Tag (4)

  • マーカー

    Unconjugated (5)Biotin-labeled (2)

IL-2 R gamma分子の別称

IL2RG,CD132,CIDX,IMD4,P64,SCIDX,SCIDX1,gammaC

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MB-107IND-14570; MB-107Phase 2 ClinicalNational Heart, Lung And Blood Institute, National Institute Of Allergy And Infectious Diseases (Niaid), National Institute of Health, Islamabad, St. Jude Children'S Research HospitalImmunologic Deficiency Syndromes; X-Linked Combined Immunodeficiency Diseases
詳細
AWT-020AWT020; AWT-020; JS213; JS-213Phase 2 ClinicalAnwita Biosciences IncAutoimmune Diseases of the Nervous System; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Solid tumours
詳細
GI-101SIM-323; SIM323; SIM0323; GI-101Phase 2 ClinicalGI Innovation IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Neoplasms; Solid tumours; Uterine Cervical Neoplasms
詳細
MB-501MB501; MB-501Phase 2 ClinicalAscendis Pharma IncNeoplasms
詳細
PegenzileukinIBI-127; THOR-707; SAR-444245Phase 2 ClinicalSynthorx IncCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Hodgkin Disease; Intestinal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma; Mesothelioma; Multiple Myeloma; Neoplasm Metastasis; Oropharyngeal Neoplasms; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
詳細
LTC-004LTC004; LTC-004Phase 2 ClinicalLeto Laboratories Co LtdColorectal Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Solid tumours
詳細
TransCon IL-2 β/γPhase 2 ClinicalAscendis Pharma A/SCarcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours
詳細
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteX-Linked Combined Immunodeficiency Diseases
詳細
Simlukafusp alfaFAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FPPhase 1 ClinicalF. Hoffmann-La Roche LtdBreast Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Head and Neck Neoplasms; Melanoma; Solid tumours; Uterine Cervical Neoplasms
詳細
BJ-001(Boji Biomedical Technology)BJ-001Phase 1 ClinicalBoji Biomedical Technology (Hangzhou) Co LtdCommunicable Diseases; Neoplasm Metastasis; Solid tumours
詳細
ex vivo IL2RG stem cell-based gene therapy (Genethon/University College London/Hannover Medical School)Phase 1 ClinicalGenethonSevere Combined Immunodeficiency
詳細
PD 1-proIL-2v (Proviva Therapeutics)PTX-912Phase 1 ClinicalProviva Therapeutics IncNeoplasm Metastasis; Neoplasms; Solid tumours
詳細
NL-201 (Neoleukin Therapeutics)NL-201Phase 1 ClinicalNeoleukin Therapeutics IncSolid tumours
詳細
Recombinant human interleukin 15(Beijing Kawin)Phase 1 ClinicalBeijing Kawin Technology Share-Holding Co LtdSolid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8